Supplementation Of Analog Rice İn Combination With Metformin Prevent Myocardial Cell Death İn Type 2 Diabetuc Rats

Andi Muhammad; Jauhar Firdaus; Nindya Shinta Rumastika; Hairrudin Hairrudin; Elly Nurus Sakinah

doi:10.47134/ijhis.v3i1.55

Authors

Andi Muhammad Universitas Jember
Jauhar Firdaus Universitas Jember
Nindya Shinta Rumastika Universitas Jember
Hairrudin Universitas Jember
Elly Nurus Sakinah Universitas Jember

DOI:

https://doi.org/10.47134/ijhis.v3i1.55

Keywords:

diabetes, heart, analog rice, myocardial cell death, metformin, MOCAF

Abstract

Type 2 diabetes (T2D) is an urgent health issue that leads to one of the most significant cardiovascular complications worldwide, diabetic cardiomyopathy (DCM), which is associated with high morbidity and mortality. Chronic hyperglycemia and oxidative stress are major contributor for DCM. Analog rice based of MOCAF and corn starch is a functional food recommended as nutritional supplementation to replace staple foods in T2D patients. Analog rice has a high fiber content, high resistant starch and low glycemic index, which can help lower blood sugar levels and prevent DM complications. MOCAF in analog rice is also rich in phenolic compounds, which has potential effect of antioxidant. Metformin is the first line oral therapy for T2D. The present study investigates the potential effects of an analog rice diet in combination with metformin, for the development of DCM. Type 2 diabetic rats were induced by HFD/STZ method and was treated by analog rice and metformin for 4 weeks. Myocardial cell death measured by pyknotic nuclei percentage was analysed. The study result demonstrate that analog rice and metformin prevent the myocardial cell damage observed in type 2 diabetic animals, highlighting analog rice potential as adjuvant therapy, for treating DCM has no clinical significance than metformin therapy alone.

References

[1] I. D. Federation, IDF Diabetes Atlas, 10th ed. Brussels, Belgium: International Diabetes Federation, 2021.

[2] B. Parim, V. V. S. Uddandrao, and G. Saravanan, “Diabetic cardiomyopathy : molecular mechanisms , detrimental effects of conventional treatment , and beneficial effects of natural therapy,” pp. 279–299, 2019.

[3] T. Li et al., “Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus,” pp. 1–12, 2021, doi: 10.1186/s12933-020-01202-5.

[4] E. Garc, A. Caro-vadillo, P. Francisco, P. Jara, and S. Ramos, “Supplementation with a Cocoa – Carob Blend , Alone or in Combination with Metformin , Attenuates Diabetic Cardiomyopathy , Cardiac Oxidative Stress and Inflammation in Zucker Diabetic Rats,” no. DCM, pp. 1–17, 2022.

[5] M. P. Zaveri, J. C. Perry, T. M. Schuetz, M. D. Memon, and S. Faiz, “Diabetic Cardiomyopathy as a Clinical Entity : Is It a Myth ?,” vol. 12, no. 10, 2020, doi: 10.7759/cureus.11100.

[6] N. M. Al-rasheed et al., “Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats,” vol. 2017, 2017, doi: https://doi.org/10.1155/2017/1092015.

[7] T. Mohamed et al., “The potential protective effects of diosmin on streptozotocin-induced diabetic cardiomyopathy in rats,” Am. J. Med. Sci., 2019, doi: 10.1016/j.amjms.2019.10.005.

[8] A. A. A. Kayode, G. O. Adebodun, D. I. Fabunmi, and O. T. Kayode, “Role of functional foods in the management of diabetes mellitus : a concise review,” vol. 2, no. 7, pp. 29–41, 2023.

[9] C. Lauwis, C. T. Maringka, F. Julieta, P. Evangelista, and V. Marcellino, “Antidiabetic properties of analog rice from local raw materials : a systematic review,” vol. 12, no. 2, 2023, doi: 10.11591/ijphs.v12i2.22130.

[10] Hairrudin, Soetjipto, and Handajani, “Hypoglycemic Effect of High-Resistant Starch Analog Rice Through Glp-1 and Insulin or High-Resistant Starch Analog Rice Attenuates Blood Glucose Level Through Enhancement of Glp-1 and Insulin,” Asian J. Pharm. Clin. Res., vol. 12, no. 8, pp. 172–175, 2019, doi: 10.22159/ajpcr.2019.v12i18.33944.

[11] A. Darajat and E. N. Sakinah, “Efek kandungan serat beras analog terhadap ekspresi GLUT4 otot rangka tikus diabetes,” vol. 16, no. 1, pp. 14–21, 2019, doi: 10.22146/ijcn.31806.

[12] S. A. Adefegha, G. Oboh, B. M. Okeke, and S. I. Oyeleye, “Effects of processing on starch composition , glycemic indices , phenolic profile , and possible antidiabetic properties of cassava ( Manihot esculenta ) flours,” no. August 2020, pp. 1–9, 2021, doi: 10.1111/jfpp.15586.

[13] T. Salvatore et al., “Effects of Metformin in Heart Failure : From Pathophysiological Rationale to Clinical Evidence,” Biomolecules, vol. 11, no. 1834, pp. 1–23, 2021, doi: https://doi.org/10.3390/biom11121834.

[14] S. Palee, L. Higgins, T. Leech, S. C. Chattipakorn, and N. Chattipakorn, “Biomedicine & Pharmacotherapy Acute metformin treatment provides cardioprotection via improved mitochondrial function in cardiac ischemia / reperfusion injury,” Biomed. Pharmacother., vol. 130, no. May, p. 110604, 2020, doi: 10.1016/j.biopha.2020.110604.

[15] S. Skovsø, “Modeling type 2 diabetes in rats using high fat diet and streptozotocin,” vol. 5, no. 4, pp. 349–358, 2014, doi: 10.1111/jdi.12235.

[16] Kume, C. Fs, Q. Ts, A. N. Ew, and K. Nh, “High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus : a new proposal,” vol. 91, pp. 1–14, 2019, doi: 10.1590/0001-3765201920180314.Abstract.

[17] M. Mizamtsidi, S. A. Paschou, J. Grapsa, and A. Vryonidou, “Diabetic Cardiomyopathy: a clinical entity or a cluster of molecular heart changes?,” 2016, doi: 10.1111/eci.12673.

[18] G. Murtaza et al., “Progress in Cardiovascular Diseases Diabetic cardiomyopathy - A comprehensive updated review,” Prog. Cardiovasc. Dis., vol. 62, no. 4, pp. 315–326, 2019, doi: 10.1016/j.pcad.2019.03.003.

[19] L. Hou, K. Liu, Y. Li, S. Ma, X. Ji, and L. Liu, “Necrotic pyknosis is a morphologically and biochemically distinct event from apoptotic pyknosis,” pp. 3084–3090, 2016, doi: 10.1242/jcs.184374.

[20] S. F. Santagostino, C. Assenmacher, J. C. Tarrant, A. O. Adedeji, and E. Radaelli, “Mechanisms of Regulated Cell Death : Current Perspectives,” vol. 58, no. 4, pp. 596–623, 2021, doi: 10.1177/03009858211005537.

[21] M. Nugraheni, S. Purwanti, and P. Ekawatiningsih, “Chemical composition, glycaemic index, and antidiabetic property of analogue rice made from composite tubers, germinated legumes, and cereal flours,” Int. Food Res. J., vol. 29, no. 6, pp. 1304–1313, 2022, doi: 10.47836/ifrj.29.6.07.